JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES) ›› 2012, Vol. 50 ›› Issue (5): 124-128.

• Articles • Previous Articles     Next Articles

The economic burden of bronchial asthma and its related factors in Jinan

WANG De-xiang1, JI Xiu-li1,2, MA De-dong1, ZHANG Yu-ke1, HE Bao-long1,
WANG Wen-qiao1, XIAO Wei1   

  1. 1. Department of Respiratory, Qilu Hospital of Shandong University, Jinan 250012, China;
    2. Department of Respiratory, Jinan Municipal Hospital of Traditional Chinese Medicine, Jinan 250012
  • Received:2012-02-12 Online:2012-05-10 Published:2012-05-10

Abstract:

Objective   To investigate the economic burden of asthma in Jinan, and to analyze its influencing factors. Methods   Data of 152 asthma patients chosen from 13419 residents  through randomized cluster sampling in the asthma epidemiologic survey in Jinan, Shandong Province in 2009 were analyzed. The economic burdens of asthma in both the urban and the rural area of Jinan were assessed through the direct method and human capital method. The Chi-square test and multiple logistic regression analysis were employed to investigate the related factors of expenses of asthma treatment. Results   The prevalence of asthma was 1.1% in Jinan. The economic burden of diseases was 290 million yuan, including 253 million yuan for the direct economic burden and 37 million yuan for the indirect economic burden. The average burden per capita was 4378 yuan. Complication with allergic rhinitis or other cardio-pulmonary diseases, hospitalization for asthma, smoking index and overuse of antibiotics were the main impact factors on the asthma burden in Jinan. Conclusion   The economic burden of bronchial asthma for patients in Jinan is heavy. Smoking and overuse of antibiotics were the main but controllable factors for the increased economic burden. Tobacco control, implementation of standard asthma treatment and avoiding overuse of antibiotics can effectively eradicate medical resources waste and decrease the economic burden of asthma.

Key words: Bronchial asthma; Economic burden; Impact factors

CLC Number: 

  • R562.2
[1] PENG Xiao-nu1,2, LI Wen-jun2, TIAN Hui1. Poly(ADP-ribose) polymerase 1 inhibition protects human bronchial endothelial cells against nicotineinduced inflammation response [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(2): 37-43.
[2] CHI Xiang-yu1, LI Qing1, WANG Lai-cheng2, WANG Jing1 . Association between the ADAM33 gene polymorphism and bronchial asthma [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2010, 48(10): 77-80.
[3] CHAI Jing1, JIANG Ping2, QIAN Xuejiao1. Diagnostic value of  fractional exhaled nitric oxide measurement in bronchial asthma  [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2010, 48(10): 81-84.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!